Clinical Trial Update: A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of tirzepatide on stomach emptying in overweight/obese individuals, including participants with Type 2 diabetes; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2024-01-08